Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells
- 1 January 2016
- journal article
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 306 (1) , 38-47
Abstract
No abstract availableKeywords
Funding Information
- Czech Science Foundation (GA15-09157S, GA13-14547S)
- Crucell Holland B.V. (RVO61388971)
This publication has 53 references indexed in Scilit:
- Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchangeBMC Microbiology, 2012
- Bordetella Pertussis Toxin does not induce the release of pro-inflammatory cytokines in human whole bloodMedical Microbiology and Immunology, 2012
- Modulation of the Host Interferon Response and ISGylation Pathway by B. pertussis Filamentous HemagglutininPLOS ONE, 2011
- Pertussis Disease Burden in the Household: How to Protect Young InfantsClinical Infectious Diseases, 2010
- Substitution of the Bordetella pertussis Lipid A Phosphate Groups with Glucosamine Is Required for Robust NF-κB Activation and Release of Proinflammatory Cytokines in Cells Expressing Human but Not Murine Toll-Like Receptor 4-MD-2-CD14Infection and Immunity, 2010
- Bordetella pertussis Commits Human Dendritic Cells to Promote a Th1/Th17 Response through the Activity of Adenylate Cyclase Toxin and MAPK-PathwaysPLOS ONE, 2010
- Monocyte-Derived Interleukin-10 Depresses the Bordetella pertussis - Specific Gamma Interferon Response in Vaccinated InfantsClinical and Vaccine Immunology, 2009
- Modulation of the NF-κB Pathway by Bordetella pertussis Filamentous HemagglutininPLOS ONE, 2008
- Pathology and Pathogenesis of FatalBordetella pertussisInfection in InfantsClinical Infectious Diseases, 2008
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005